News
XtalPi’s Hair Loss Drug Programme Enters IND-Enabling Studies
XtalPi’s hair loss drug candidate targets a lactate–autophagy pathway to reactivate quiescent hair follicle stem cells.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
XtalPi’s hair loss drug candidate targets a lactate–autophagy pathway to reactivate quiescent hair follicle stem cells.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
